Amphastar Pharmaceuticals Inc (AMPH) Company Profile & Statistics

Amphastar Pharmaceuticals Inc
AMPH
(Nasdaq - US)
Closed
45.43
+0.88 (+1.98%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
Open
45.26
High
45.65
Low
44.96

About Amphastar Pharmaceuticals Inc

CEO

Jack Yongfeng Zhang

Headquarters

11570 sixth street

rancho cucamonga, ca 91730, united states

Auditor

Ernst & Young LLP

Employees

1,761

Share Holders

120

Website

www.amphastar.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Amphastar Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	2.18B
Enterprise Value	2.59B
Enterprise Value/EBITDA (ttm)	9.42
Price to Earnings Ratio (ttm)	12.61
Price to Book (mrq)	2.92
Price to Sales (ttm)	2.90
Price to Cash (ytd)	9.99

Profitability

Gross Margin (ttm)	52.98%
Operating Margin (ttm)	25.15%
Profit Margin (ttm)	21.85%
Return on Equity (ttm)	26.44%
Return on Invested Capital (ttm)	12.32%
Return on Assets (ttm)	11.89%

Income Statement

Revenue (ttm)	723.55M
Revenue Per Share (ttm)	15.05
Gross Profit (ttm)	383.35M
EBITDA (ttm)³	274.83M
Net Income Avi to Common (ttm)	157.72M
Diluted EPS (ttm)	3.00

Share Statistics

Beta (5Y Monthly)	0.82
52-Week Change	-19.72%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	48.08M
Dividend Yield	0.00%
Float ⁴	35.05M
% Held by Insiders	27.10%
% Held by Institutions	65.09%

Balance Sheet

Total Cash (mrq)	252.93M
Total Cash Per Share (mrq)	5.26
Total Debt (mrq)	596.70M
Total Debt/Equity (mrq)	82.00%
Current Ratio (mrq)	3.43%
Quick Ratio (mrq)	2.61%
Book Value Per Share (mrq)	15.04

Cash Flow

Operating Cash Flow Per Share (ytd)	3.55
Free Cash Flow (ytd)	155.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Amphastar Pharmaceuticals Inc

Trade With A Regulated Broker